A clean-label patch offers a low-commitment trial before pursuing care
This formulation is specifically designed to address conditions such as neuropathy, anemia, B12 deficiency, megaloblastic anemia, and Leber's disease
By neutralizing harmful molecules, it aids in slowing down the aging process, reducing the appearance of fine lines, wrinkles, and other signs of skin damage
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
Habig WH, Pabst MJ, Jakoby WB
